Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Engineered nanoparticles to enhance natural killer cell activity towards onco-immunotherapy: a review
Cao Dai Phung, Tuan Hiep Tran, Jong Oh Kim
Archives of Pharmacal Research (2020) Vol. 43, Iss. 1, pp. 32-45
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Theranostic applications of selenium nanomedicines against lung cancer
Shaowei Liu, Weifeng Wei, Jinlin Wang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 42
Current developments in nanotechnology for improved cancer treatment, focusing on tumor hypoxia
Cao Dai Phung, Tuan Hiep Tran, Le Minh Pham, et al.
Journal of Controlled Release (2020) Vol. 324, pp. 413-429
Closed Access | Times Cited: 100
Anti-CTLA-4 antibody-functionalized dendritic cell-derived exosomes targeting tumor-draining lymph nodes for effective induction of antitumor T-cell responses
Cao Dai Phung, Tung Thanh Pham, Hanh Thuy Nguyen, et al.
Acta Biomaterialia (2020) Vol. 115, pp. 371-382
Closed Access | Times Cited: 89
Engineering customized nanovaccines for enhanced cancer immunotherapy
JinYu Guo, Changhua Liu, Zhaoyang Qi, et al.
Bioactive Materials (2024) Vol. 36, pp. 330-357
Open Access | Times Cited: 12
Cationic Nanoparticle-Mediated Activation of Natural Killer Cells for Effective Cancer Immunotherapy
Dong Hwan Kim, Jun‐Hyeok Han, Seung Hee Choi, et al.
ACS Applied Materials & Interfaces (2020) Vol. 12, Iss. 51, pp. 56731-56740
Closed Access | Times Cited: 56
Advances in Nanomaterials for Immunotherapeutic Improvement of Cancer Chemotherapy
Jie Liu, Bei Li, Li Li, et al.
Small (2024)
Closed Access | Times Cited: 7
Natural killer (NK) cell-based immunotherapies and the many faces of NK cell memory: A look into how nanoparticles enhance NK cell activity
Idoia Mikelez-Alonso, Susana Magadán, África González‐Fernández, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113860-113860
Closed Access | Times Cited: 40
Targeting the innate immune system with nanoparticles for cancer immunotherapy
Kai Li, Zhicheng Zhang, Yu Mei, et al.
Journal of Materials Chemistry B (2022) Vol. 10, Iss. 11, pp. 1709-1733
Closed Access | Times Cited: 23
Emerging applications of nanotechnology in context to immunology: A comprehensive review
Hifsa Mobeen, Muhammad Safdar, Asma Fatima, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 23
Drug delivery systems for colorectal cancer chemotherapy
Wen Chen, Kun Shi, Yan Yu, et al.
Chinese Chemical Letters (2023) Vol. 35, Iss. 2, pp. 109159-109159
Closed Access | Times Cited: 14
Recent Advances to Augment NK Cell Cancer Immunotherapy Using Nanoparticles
Dong Hwan Kim, Dong‐Hwan Kim, Dong‐Hyun Kim
Pharmaceutics (2021) Vol. 13, Iss. 4, pp. 525-525
Open Access | Times Cited: 27
PEGylated-Paclitaxel and Dihydroartemisinin Nanoparticles for Simultaneously Delivering Paclitaxel and Dihydroartemisinin to Colorectal Cancer
Cao Dai Phung, Thien Giap Le, Van Hai Nguyen, et al.
Pharmaceutical Research (2020) Vol. 37, Iss. 7
Closed Access | Times Cited: 29
Nanobiomaterials to modulate natural killer cell responses for effective cancer immunotherapy
Aun Raza, Gustavo Rodrigues Rossi, Taskeen Iqbal Janjua, et al.
Trends in biotechnology (2022) Vol. 41, Iss. 1, pp. 77-92
Closed Access | Times Cited: 18
Improved cancer immunotherapy strategies by nanomedicine
Shuai Guo, Jie Feng, Zongheng Li, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2022) Vol. 15, Iss. 3
Closed Access | Times Cited: 18
The basic biology of NK cells and its application in tumor immunotherapy
Pan Jiang, Shaoze Jing, Gaohong Sheng, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Hyperthermal paclitaxel-bound albumin nanoparticles co-loaded with indocyanine green and hyaluronidase for treating pancreatic cancers
Sung Soo Kim, Hwang Kyung Kim, Hanju Kim, et al.
Archives of Pharmacal Research (2020) Vol. 44, Iss. 2, pp. 182-193
Closed Access | Times Cited: 25
CD48-expressing non-small-cell lung cancer cells are susceptible to natural killer cell–mediated cytotoxicity
Eun Jae Park, Hye Won Jun, Ik Ho Na, et al.
Archives of Pharmacal Research (2021) Vol. 45, Iss. 1, pp. 1-10
Closed Access | Times Cited: 20
The role of CCL2, CCL7, ICAM-1, and VCAM-1 in interaction of endothelial cells and natural killer cells
Hye Won Jun, Hong Kyung Lee, Ik Ho Na, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109332-109332
Closed Access | Times Cited: 13
Overexpression of AGR2 Is Associated With Drug Resistance in Mutant Non-small Cell Lung Cancers
Thi-Thu-Trang Luu, Duc‐Hiep Bach, Donghwa Kim, et al.
Anticancer Research (2020) Vol. 40, Iss. 4, pp. 1855-1866
Open Access | Times Cited: 16
Optically Coupled PtOEP and DPA Molecules Encapsulated into PLGA-Nanoparticles for Cancer Bioimaging
Olena Vepris, Christina Eich, Yansong Feng, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1070-1070
Open Access | Times Cited: 10
Nanovaccines silencing IL-10 production at priming phase for boosting immune responses to melanoma
Cao Dai Phung, Tuan Hiep Tran, Hanh Thuy Nguyen, et al.
Journal of Controlled Release (2021) Vol. 338, pp. 211-223
Closed Access | Times Cited: 14
Shaping the “hot” immunogenic tumor microenvironment by nanoparticles co‐delivering oncolytic peptide and TGF‐β1 siRNA for boosting checkpoint blockade therapy
Cao Dai Phung, Bảo Lộc Nguyễn, Jee‐Heon Jeong, et al.
Bioengineering & Translational Medicine (2022) Vol. 8, Iss. 5
Open Access | Times Cited: 9
Cell- and subcellular organelle-targeting nanoparticle-mediated breast cancer therapy
Xue Wei, Ming Yang
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
Driving natural killer cell-based cancer immunotherapy for cancer treatment: An arduous journey to promising ground
Dandan Jiang, Jingya Zhang, Zhenkun Mao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115004-115004
Open Access | Times Cited: 5
The Effect of PEGylation on Drugs’ Pharmacokinetic Parameters; from Absorption to Excretion
Ali Khajeei, Salar Masoomzadeh, Tooba Gholikhani, et al.
Current Drug Delivery (2023) Vol. 21, Iss. 7, pp. 978-992
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top